Evidence map›Paper›PMID 31361571›Full record

ArticleThe Journal of urology2020

The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns.

Bruce L Jacobs, Jonathan G Yabes, Samia H Lopa, Dwight E Heron, Chung-Chou H Chang, Justin E Bekelman, Joel B Nelson, Julie P W Bynum, Amber E Barnato, Jeremy M Kahn

Open access · greenAbstract read
In one paragraph

Article in The Journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Bruce L JacobsDepartments of Urology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jonathan G YabesDepartments of Urology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Samia H LopaDepartments of Urology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Dwight E HeronDepartment of Medicine, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Chung-Chou H ChangRadiation Oncology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Justin E BekelmanDepartment of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Joel B NelsonDepartments of Urology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Julie P W BynumLeonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania.
Amber E BarnatoDartmouth Institute for Health Policy and Clinical Practice, Lebanon and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Jeremy M KahnCritical Care Medicine, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · USDartmouth Institute for Health Policy and Clinical Practice · USGTx (United States) · USUniversity of Michigan–Ann Arbor · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Leonard J. Appleman · 1988 to 2026
$158.0M
UNDERSTANDING AND IMPROVING EPISODE-BASED HOSPITAL CAREP01AG019783 · NIA · DARTMOUTH COLLEGE · PI Inas S Khayal · 2001 to 2026
$52.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
The role of long term acute care hospitals in prolonged mechanical ventilationR01HL096651 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAHN, JEREMY M · 2009 to 2018
$3.6M
Patient Oriented Research and Mentoring in Critical Care Implementation ScienceK24HL133444 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAHN, JEREMY M · 2016 to 2018
$348k
Enriching Claims-Based Analysis of Prostate Cancer Treatment Decision MakingR03AG048091 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JACOBS, BRUCE L. · 2014 to 2015
$228k
NCATS NIH HHS UL1 TR000005NCI NIH HHS P30 CA047904NHLBI NIH HHS K24 HL133444NHLBI NIH HHS R01 HL096651NIA NIH HHS P01 AG019783NIA NIH HHS R03 AG048091
6 · The paper itself

Abstract

purposeTo our knowledge it is unknown whether stereotactic body radiation therapy of prostate cancer is a substitute for other radiation treatments or surgery, or for expanding the pool of patients who undergo treatment instead of active surveillance. MATERIALS AND

methodsUsing SEER (Surveillance, Epidemiology, and End Results)-Medicare we identified men diagnosed with prostate cancer between 2007 and 2011. We developed physician-hospital networks by identifying the treating physician of each patient based on the primary treatment received and subsequently assigning each physician to a hospital. We examined the relative distribution of prostate cancer treatments stratified by whether stereotactic body radiation therapy was performed in a network by fitting logistic regression models with robust SEs to account for patient clustering in networks.

resultsWe identified 344 physician-hospital networks, including 30 (8.7%) and 314 (91.3%) in which stereotactic body radiation therapy was and was not performed, respectively. Networks in which that therapy was and was not done did not differ with time in the performance of robotic and radical prostatectomy, and active surveillance (all p >0.05). The relationship with intensity modulated radiation therapy did not show any consistent temporal pattern. In networks in which it was performed less intensity modulated radiation therapy was initially done but there were similar rates in later years. Brachytherapy trends differed among networks in which stereotactic body radiation therapy was vs was not performed with a lower brachytherapy rate in networks in which stereotactic body radiation therapy was done (p=0.03).

conclusionsSurgery and active surveillance rates did not differ in networks in which stereotactic body radiation therapy was vs was not performed but when that therapy was done there was a lower brachytherapy rate. Stereotactic body radiation therapy may represent more of an alternative to brachytherapy than to active surveillance.

Indexed as

RadiosurgeryAgedHumansLongitudinal StudiesMalePractice Patterns, Physicians'Prostatic NeoplasmsSEER ProgramUnited Statesbrachytherapyprostatic neoplasmsradiotherapySEER Programwatchful waiting

Identifiers

PMID31361571
PMCPMC7946357
OpenAlexW2965517456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.